265 related articles for article (PubMed ID: 10367477)
1. Applications of reconstructed skin models in pharmaco-toxicological trials.
Damour O; Augustin C; Black AF
Med Biol Eng Comput; 1998 Nov; 36(6):825-32. PubMed ID: 10367477
[TBL] [Abstract][Full Text] [Related]
2. Alternatives to the use of animals in safety testing as required by the EU-Cosmetics Directive 2009.
Vogel R
ALTEX; 2009; 26(3):223-6. PubMed ID: 19907908
[TBL] [Abstract][Full Text] [Related]
3. The use and interpretation of in vitro data in regulatory toxicology: cosmetics, toiletries and household products.
Indans I
Toxicol Lett; 2002 Feb; 127(1-3):177-82. PubMed ID: 12052656
[TBL] [Abstract][Full Text] [Related]
4. Alternative in vitro models used in the main safety tests of cosmetic products and new challenges.
Filaire E; Nachat-Kappes R; Laporte C; Harmand MF; Simon M; Poinsot C
Int J Cosmet Sci; 2022 Dec; 44(6):604-613. PubMed ID: 35842748
[TBL] [Abstract][Full Text] [Related]
5. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing.
McKim JM; Keller DJ; Gorski JR
Cutan Ocul Toxicol; 2012 Dec; 31(4):292-305. PubMed ID: 22494060
[TBL] [Abstract][Full Text] [Related]
6. Current EU regulatory requirements for the assessment of chemicals and cosmetic products: challenges and opportunities for introducing new approach methodologies.
Pistollato F; Madia F; Corvi R; Munn S; Grignard E; Paini A; Worth A; Bal-Price A; Prieto P; Casati S; Berggren E; Bopp SK; Zuang V
Arch Toxicol; 2021 Jun; 95(6):1867-1897. PubMed ID: 33851225
[TBL] [Abstract][Full Text] [Related]
7. Industry experience with alternative methods.
LeClaire J; de Silva O
Toxicol Lett; 1998 Dec; 102-103():575-9. PubMed ID: 10022316
[TBL] [Abstract][Full Text] [Related]
8. Safety evaluation of cosmetics in the EU. Reality and challenges for the toxicologist.
Pauwels M; Rogiers V
Toxicol Lett; 2004 Jun; 151(1):7-17. PubMed ID: 15177635
[TBL] [Abstract][Full Text] [Related]
9. The 3T3 neutral red uptake phototoxicity test: practical experience and implications for phototoxicity testing--the report of an ECVAM-EFPIA workshop.
Ceridono M; Tellner P; Bauer D; Barroso J; Alépée N; Corvi R; De Smedt A; Fellows MD; Gibbs NK; Heisler E; Jacobs A; Jirova D; Jones D; Kandárová H; Kasper P; Akunda JK; Krul C; Learn D; Liebsch M; Lynch AM; Muster W; Nakamura K; Nash JF; Pfannenbecker U; Phillips G; Robles C; Rogiers V; Van De Water F; Liminga UW; Vohr HW; Wattrelos O; Woods J; Zuang V; Kreysa J; Wilcox P
Regul Toxicol Pharmacol; 2012 Aug; 63(3):480-8. PubMed ID: 22687423
[TBL] [Abstract][Full Text] [Related]
10. In Silico Models for Skin Sensitization and Irritation.
Selvestrel G; Robino F; Russo MZ
Methods Mol Biol; 2022; 2425():291-354. PubMed ID: 35188638
[TBL] [Abstract][Full Text] [Related]
11. Non-animal testing strategies for assessment of the skin corrosion and skin irritation potential of ingredients and finished products.
Robinson MK; Cohen C; de Fraissinette Ade B; Ponec M; Whittle E; Fentem JH
Food Chem Toxicol; 2002 May; 40(5):573-92. PubMed ID: 11955663
[TBL] [Abstract][Full Text] [Related]
12. Safety assessment of a novel active ingredient, acetyl aspartic acid, according to the EU Cosmetics Regulation and the Scientific Committee on Consumer Safety guidelines.
Daly P; Moran G
Int J Cosmet Sci; 2015 Oct; 37 Suppl 1():21-7. PubMed ID: 26114401
[TBL] [Abstract][Full Text] [Related]
13. A tiered approach to the use of alternatives to animal testing for the safety assessment of cosmetics: skin irritation.
Macfarlane M; Jones P; Goebel C; Dufour E; Rowland J; Araki D; Costabel-Farkas M; Hewitt NJ; Hibatallah J; Kirst A; McNamee P; Schellauf F; Scheel J
Regul Toxicol Pharmacol; 2009 Jul; 54(2):188-96. PubMed ID: 19393278
[TBL] [Abstract][Full Text] [Related]
14. Insights on in vitro models for safety and toxicity assessment of cosmetic ingredients.
Almeida A; Sarmento B; Rodrigues F
Int J Pharm; 2017 Mar; 519(1-2):178-185. PubMed ID: 28104405
[TBL] [Abstract][Full Text] [Related]
15. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
16. How to assess the mutagenic potential of cosmetic products without animal tests?
Speit G
Mutat Res; 2009 Aug; 678(2):108-12. PubMed ID: 19379833
[TBL] [Abstract][Full Text] [Related]
17. In vitro skin irritation: facts and future. State of the art review of mechanisms and models.
Welss T; Basketter DA; Schröder KR
Toxicol In Vitro; 2004 Jun; 18(3):231-43. PubMed ID: 15046769
[TBL] [Abstract][Full Text] [Related]
18. Test guidelines for assessment of skin compatibility of cosmetic finished products in man. Task Force of COLIPA.
Walker AP; Basketter DA; Baverel M; Diembeck W; Matthies W; Mougin D; Paye M; Röthlisberger R; Dupuis J
Food Chem Toxicol; 1996 Jul; 34(7):651-60. PubMed ID: 8761358
[No Abstract] [Full Text] [Related]
19. Novel strategies for toxicological risk assessments.
Roy A; Akbarsha MA
ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760
[No Abstract] [Full Text] [Related]
20. Amended final report on the safety assessment of glyceryl dilaurate, glyceryl diarachidate, glyceryl dibehenate, glyceryl dierucate, glyceryl dihydroxystearate, glyceryl diisopalmitate, glyceryl diisostearate, glyceryl dilinoleate, glyceryl dimyristate, glyceryl dioleate, glyceryl diricinoleate, glyceryl dipalmitate, glyceryl dipalmitoleate, glyceryl distearate, glyceryl palmitate lactate, glyceryl stearate citrate, glyceryl stearate lactate, and glyceryl stearate succinate.
Int J Toxicol; 2007; 26 Suppl 3():1-30. PubMed ID: 18273450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
